144 related articles for article (PubMed ID: 30691592)
21. Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation.
Siegel AB; Lim EA; Wang S; Brubaker W; Rodriguez RD; Goyal A; Jacobson JS; Hershman DL; Verna EC; Zaretsky J; Halazun K; Dove L; Brown RS; Neugut AI; Kato T; Remotti H; Coppleson YJ; Emond JC
Transplantation; 2012 Sep; 94(5):539-43. PubMed ID: 22864187
[TBL] [Abstract][Full Text] [Related]
22. Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors.
Croome KP; Lee DD; Keaveny AP; Taner CB
Transplantation; 2016 Dec; 100(12):2640-2647. PubMed ID: 27861295
[TBL] [Abstract][Full Text] [Related]
23. Long-Term Outcomes of Living Donor Versus Deceased Donor Liver Transplant for Hepatocellular Carcinoma in the United States.
Muhammad H; Gurakar M; Ting PS; Alsughayer AM; Luu H; Zaffar D; Alqahtani S; Bonder A; Gurakar A; Saberi B
Exp Clin Transplant; 2022 Mar; 20(3):279-284. PubMed ID: 35352634
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Liver Transplant-Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States.
Berry K; Ioannou GN
Gastroenterology; 2015 Sep; 149(3):669-80; quiz e15-6. PubMed ID: 26021233
[TBL] [Abstract][Full Text] [Related]
25. Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching.
Angelico M; Cillo U; Fagiuoli S; Gasbarrini A; Gavrila C; Marianelli T; Costa AN; Nardi A; Strazzabosco M; Burra P; Agnes S; Baccarani U; Calise F; Colledan M; Cuomo O; De Carlis L; Donataccio M; Ettorre GM; Gerunda GE; Gridelli B; Lupo L; Mazzaferro V; Pinna A; Risaliti A; Salizzoni M; Tisone G; Valente U; Rossi G; Rossi M; Zamboni F;
Dig Liver Dis; 2011 Feb; 43(2):155-64. PubMed ID: 21185796
[TBL] [Abstract][Full Text] [Related]
26. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
Taniguchi M
Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
[TBL] [Abstract][Full Text] [Related]
27. Potential role of the donor in hepatocellular carcinoma recurrence after liver transplantation.
Vagefi PA; Dodge JL; Yao FY; Roberts JP
Liver Transpl; 2015 Feb; 21(2):187-94. PubMed ID: 25371243
[TBL] [Abstract][Full Text] [Related]
28. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
Zavaglia C; De Carlis L; Alberti AB; Minola E; Belli LS; Slim AO; Airoldi A; Giacomoni A; Rondinara G; Tinelli C; Forti D; Pinzello G
Am J Gastroenterol; 2005 Dec; 100(12):2708-16. PubMed ID: 16393224
[TBL] [Abstract][Full Text] [Related]
29. AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.
Yaprak O; Akyildiz M; Dayangac M; Demirbas BT; Guler N; Dogusoy GB; Yuzer Y; Tokat Y
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):256-61. PubMed ID: 22672818
[TBL] [Abstract][Full Text] [Related]
30. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
[TBL] [Abstract][Full Text] [Related]
31. Identifying patients at higher risk of hepatocellular carcinoma recurrence after liver transplantation in a multicenter cohort study from Argentina.
Piñero F; Marciano S; Anders M; Orozco Ganem F; Zerega A; Cagliani J; Andriani O; de Santibañes E; Gil O; Podestá LG; McCormack L; Gadano A; Silva M
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):421-7. PubMed ID: 26684693
[TBL] [Abstract][Full Text] [Related]
32. Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses.
Wong TCL; Ng KKC; Fung JYY; Chan AAC; Cheung TT; Chok KSH; Dai JWC; Lo CM
Ann Surg Oncol; 2019 May; 26(5):1454-1462. PubMed ID: 30737669
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database.
Vilchez V; Shah MB; Daily MF; Pena L; Tzeng CW; Davenport D; Hosein PJ; Gedaly R; Maynard E
HPB (Oxford); 2016 Jan; 18(1):29-34. PubMed ID: 26776848
[TBL] [Abstract][Full Text] [Related]
34. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
[TBL] [Abstract][Full Text] [Related]
35. Worse Long-term Patient Survival and Higher Cancer Rates in Liver Transplant Recipients With a History of Smoking.
Mangus RS; Fridell JA; Kubal CA; Loeffler AL; Krause AA; Bell JA; Tiwari S; Tector J
Transplantation; 2015 Sep; 99(9):1862-8. PubMed ID: 26308417
[TBL] [Abstract][Full Text] [Related]
36. Association between visceral obesity and tumor recurrence in hepatocellular carcinoma recipients undergoing liver transplantation.
Sim JH; Kim KW; Ko Y; Moon YJ; Kwon HM; Jun IG; Kim SH; Kim KS; Song JG; Hwang GS
Int J Obes (Lond); 2023 Dec; 47(12):1214-1223. PubMed ID: 37640894
[TBL] [Abstract][Full Text] [Related]
37. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
[TBL] [Abstract][Full Text] [Related]
38. Lower mean platelet volume is a risk indicator of hepatocellular carcinoma recurrence following liver transplantation.
Zhang AB; Zhang ZH; Zhang J; Lin BY; Geng L; Yang Z; Feng XN; Zheng SS
Hepatobiliary Pancreat Dis Int; 2019 Jun; 18(3):223-227. PubMed ID: 31056483
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
40. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States.
Yang JD; Larson JJ; Watt KD; Allen AM; Wiesner RH; Gores GJ; Roberts LR; Heimbach JA; Leise MD
Clin Gastroenterol Hepatol; 2017 May; 15(5):767-775.e3. PubMed ID: 28013117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
